Bhatt Amit, Abe Seiichiro, Kumaravel Arthi, Vargo John, Saito Yutaka
Department of Gastroenterology and Hepatology, Digestive Disease Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Endoscopy Division, National Cancer Center, Hospital, Tokyo, Japan.
Am J Gastroenterol. 2015 Jun;110(6):784-91. doi: 10.1038/ajg.2014.425. Epub 2015 Jan 27.
Endoscopic submucosal dissection (ESD) allows for curative resection of superficial neoplasms of the gastrointestinal tract. Although ESD is the standard of care in Japan, its adoption in the West has been slow. Recent studies have shown the advantages of ESD over endoscopic mucosal resection, and as many of the barriers to ESD have been overcome, we are seeing an increasing interest in this technique. ESD can be used to treat superficial gastric, esophageal, and colorectal lesions. The most important pre-procedure step is estimating the depth of invasion of a lesion and by proxy the risk of lymph node metastasis. After a lesion has been resected, the histopathological analysis will determine whether the resection was curative or whether further surgery is needed. In conclusion, ESD is being more widely used in the West, and it is important to understand the indications, limitations, and techniques of ESD.
内镜黏膜下剥离术(ESD)可实现胃肠道浅表肿瘤的根治性切除。尽管ESD在日本是标准治疗方法,但其在西方的应用进展缓慢。近期研究显示了ESD相较于内镜黏膜切除术的优势,并且随着ESD的诸多障碍已被克服,我们看到对该技术的兴趣日益增加。ESD可用于治疗浅表性胃、食管和结直肠病变。最重要的术前步骤是评估病变的浸润深度以及据此推断淋巴结转移风险。病变切除后,组织病理学分析将确定切除是否为根治性,或者是否需要进一步手术。总之,ESD在西方正得到更广泛应用,了解ESD的适应证、局限性和技术很重要。